Active ingredientBucillamineCat. No. P-B128-001CAS 65002-17-7Family · Pharmaceutical analytical standards
Bucillamine
An antirheumatic drug derived from cysteine and developed from tiopronin: thanks to its two thiol groups it acts as a sulfhydryl donor, and it has been prescribed for decades in Japan and South Korea for rheumatoid arthritis. This family brings together the active ingredient and labelled standards.
Did you know?In the body it is a thiol donor about 16 times more potent than acetylcysteine, the well-known mucolytic: for this reason it has also been studied to protect organs destined for transplantation.
Go to the active ingredient →Active ingredientBucillamineCat. No. P-B128-001CAS 65002-17-7
Isotopically labelledBucillamine-d6Cat. No. P-B128-002No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.